Trump admin seeks to roll back testosterone restrictions

Live updates

1. 1h ago

   FDA Panel Recommends Easing Testosterone Therapy Restrictions

   An FDA panel has advised loosening regulations on testosterone replacement therapy to increase accessibility. The group suggested modifying product labels and removing the controlled substance classification. Members argued that existing restrictions harm men's health.

   What's confirmed:

   • An FDA panel recommended easing restrictions on testosterone replacement therapy.
   • The panel advocated for changes to product labels to make therapy more accessible.

   Still unconfirmed:

   • The panel suggested removing the classification of testosterone therapies as controlled substances.
   • Current FDA labeling limits the drug to men with low testosterone caused by specific medical conditions like hypogonadism.
   confidence 100%
2. 2d ago

   Trump Administration Moves to Ease Testosterone Therapy Restrictions

   The Department of Health and Human Services is requesting updates to testosterone replacement therapy product labels. This move aims to increase access for older men who cannot produce enough of the hormone naturally. The decision has caused a divide among medical experts.

   What's confirmed:

   • The Department of Health and Human Services is requesting revisions to testosterone replacement therapy labels.
   • Robert F. Kennedy Jr. leads the Department of Health and Human Services.
   • HHS stated that 2015 warnings were based on heart risk concerns and limited evidence of benefits.
   • The administration seeks to end restrictions for older men whose bodies struggle to produce the hormone naturally.

   Still unconfirmed:

   • The FDA has lifted restrictions on testosterone replacement therapy.
   • New research suggests heart risk may not be as significant as previously feared.
   confidence 90%